Stevens-Johnson syndrome and toxic epidermal necrolysis: Follow-up of pulmonary function after remission

British Journal of Dermatology

Volumn 172, Issue 2, 2015, Pages 400-405

  Duong, T A ^a,b   De Prost, N ^a,c   Ingen Housz Oro, S ^a,b   Carrie A S ^d   Zerah, F ^a   Valeyrie Allanore, L ^a,b,e,f   Bagot, M ^g   Chosidow, O ^a,b,c,h,i   Roujeau, J C ^a,b,e   Wolkenstein, P ^a,b,c,f   Maitre, B ^c,d  

^a HENRI MONDOR HOSPITAL   (France)

^b Centre de Reference des Dermatoses Bulleuses Toxiques   (France)

^c UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e RegiSCAR Group   (France)

^f EA no EA439   (France)

^g SAINT LOUIS HOSPITAL   (France)

^h INSERM   (France)

ⁱ French Satellite of the Cochrane Skin Group   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; OXYGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY SURFACE; DYSPNEA; FEMALE; FOLLOW UP; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; REMISSION; STEVENS JOHNSON SYNDROME; TOTAL LUNG CAPACITY; TOXIC EPIDERMAL NECROLYSIS; BLOOD; COMPLICATION; DIFFUSION; FORCED EXPIRATORY VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSURE; RESPIRATION DISORDERS; VITAL CAPACITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARBON MONOXIDE; DIFFUSION; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; OXYGEN; PARTIAL PRESSURE; RESPIRATION DISORDERS; STEVENS-JOHNSON SYNDROME; TOTAL LUNG CAPACITY; VITAL CAPACITY; YOUNG ADULT;

EID: 84922788479     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13505     Document Type: Article

References (20)

1. Bastuji-Garin S, Rzany B, Stern RS, et al,. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92-6.
2. Lebargy F, Wolkenstein P, Gisselbrecht M, et al,. Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med 1997; 23: 1237-44.
3. de Prost N, Mékontso-Dessap A, Valeyrie-Allanore L, et al,. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation. Crit Care Med 2014; 42: 118-28.
4. Fellahi A, Zouhair K, Amraoui A, Benchikhi H,. [Stevens-Johnson and Lyell syndromes: mucocutaneous and ocular sequelae in 43 cases]. Ann Dermatol Venereol 2011; 138: 88-92 (in French).
5. Gueudry J, Roujeau J-C, Binaghi M, et al,. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol 2009; 145: 157-62.
6. Gaultier F, Rochefort J, Landru M-M, et al,. Severe and unrecognized dental abnormalities after drug-induced epidermal necrolysis. Arch Dermatol 2009; 145: 1332-3.
7. Meneux E, Wolkenstein P, Haddad B, et al,. Vulvovaginal involvement in toxic epidermal necrolysis: a retrospective study of 40 cases. Obstet Gynecol 1998; 91: 283-7.
8. McIvor RA, Zaidi J, Peters WJ, Hyland RH,. Acute and chronic respiratory complications of toxic epidermal necrolysis. J Burn Care Rehabil 1996; 17: 237-40.
9. Woo T, Saito H, Yamakawa Y, et al,. Severe obliterative bronchitis associated with Stevens-Johnson syndrome. Intern Med 2011; 50: 2823-7.
10. Bastuji-Garin S, Fouchard N, Bertocchi M, et al,. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000; 115: 149-53.
11. Macintyre N, Crapo RO, Viegi G, et al,. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-35.
12. Wanger J, Clausen JL, Coates A, et al,. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-22.
13. Minamihaba O, Nakamura H, Sata M, et al,. Progressive bronchial obstruction associated with toxic epidermal necrolysis. Respirology 1999; 4: 93-5.
14. Kamada N, Kinoshita K, Togawa Y, et al,. Chronic pulmonary complications associated with toxic epidermal necrolysis: report of a severe case with anti-Ro/SS-A and a review of the published work. J Dermatol 2006; 33: 616-22.
15. Dyer C,. The interaction of ageing and lung disease. Chron Respir Dis 2012; 9: 63-7.
16. Pothoff G, Wassermann K, Julius B, Hilger HH,. [Pulmonary function tests after Pneumocystis carinii pneumonia in HIV infected patients]. Pneumologie 1992; 46: 221-5 (in German).
17. Egan JJ, Lowe L, Yonan N, et al,. Pulmonary diffusion impairment following heart transplantation: a prospective study. Eur Respir J 1996; 9: 663-8.
18. Verneuil L, Ratajczak P, Allabert C, et al,. Endothelial cell apoptosis in severe drug-induced bullous eruptions. Br J Dermatol 2009; 161: 1371-5.
19. Herridge MS, Cheung AM, Tansey CM, et al,. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348: 683-93.
20. Allanore Y, Borderie D, Avouac J, et al,. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum 2008; 58: 284-91.